Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION FOR ENHANCING BREAST MILK COMPONENT
Document Type and Number:
WIPO Patent Application WO/2019/182160
Kind Code:
A1
Abstract:
Provided is a composition which can be used for a specific use application such as a composition for enhancing a milk component. A composition containing, as an active ingredient, a bacterium belonging to the genus Bifidobacterium.

Inventors:
IZUMI HIROHISA (JP)
EHARA TATSUYA (JP)
HIRAKU AKARI (JP)
MURATA MAI (JP)
IWABUCHI NORIYUKI (JP)
Application Number:
PCT/JP2019/012602
Publication Date:
September 26, 2019
Filing Date:
March 25, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MORINAGA MILK INDUSTRY CO LTD (JP)
International Classes:
A61K35/745; A61K31/702; A61K38/19; A61K38/21; A61P37/08; A61P43/00; A23C9/152; A23L33/135; A61K35/20; A61K38/16
Domestic Patent References:
WO2012096272A12012-07-19
WO2011007815A12011-01-20
WO2012096272A12012-07-19
Foreign References:
JP2010528093A2010-08-19
JP2013245174A2013-12-09
JP2007169200A2007-07-05
JP2013245174A2013-12-09
Other References:
BALDASSARRE, M. E. ET AL.: "Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial.", NUTRIENTS, vol. 8, no. 11, 2016, pages E677, XP055638892, DOI: 10.3390/nu8110677
FUKUSHIMA, Y. ET AL.: "Effect of bifidobacteria feeding on fecal flora and production of immunoglobulins in lactating mouse", INT. J. FOOD MICROBIOL., vol. 46, no. 3, 1999, pages 193 - 7, XP001024058, DOI: 10.1016/S0168-1605(98)00183-4
KIVIT, S. D. ET AL.: "Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans", ALLERGY, vol. 67, no. 3, 2012, pages 343 - 52, XP055487111, DOI: 10.1111/j.1398-9995.2011.02771.x
BALDASSARRE ME ET AL., NUTRIENTS, vol. 8, no. 11, 2016
MOHAN T ET AL., INT IMMUNOPHARMACOL, vol. 51, 2017, pages 165 - 170
MATSUO K ET AL., J IMMUNOL, vol. 200, no. 2, 2018, pages 800 - 809
YANG GY ET AL., VET RES, vol. 47, no. 1, 2016, pages 71
CASTELLETTI E ET AL., PLOS ONE, vol. 2, no. 10, 2007, pages e969
PALLISTER KB ET AL., PLOS ONE, vol. 10, no. 9, 2015, pages e0138084
SEKI M ET AL., CLIN IMMUNOL, vol. 127, no. 1, 2008, pages 78 - 88
DE KIVIT S ET AL., ALLERGY, vol. 67, no. 3, 2012, pages 343 - 52
LIEDEL JL ET AL.: "Mother's milk-induced Hsp7 0 expression preserves intestinal epithelial barrier function in an immature rat pup model", PEDIATR RES, vol. 69, May 2011 (2011-05-01), pages 395 - 400
GONG W. ET AL.: "Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication", J BIOL CHEM., vol. 273, no. 8, 20 February 1998 (1998-02-20), pages 4289 - 92
YANG D. ET AL.: "Many chemokines including CCL20/MIP-3alpha display antimicrobial activity", J LEUKOC BIOL, vol. 74, no. 3, September 2003 (2003-09-01), pages 448 - 55, XP003024983
YUAN LIN ET AL.: "CCL21 Cancer Immunotherapy", CANCERS (BASEL, vol. 6, no. 2, June 2014 (2014-06-01), pages 1098 - 1110, XP055649320, DOI: 10.3390/cancers6021098
See also references of EP 3769772A4
Attorney, Agent or Firm:
IP FIRM SHUWA (JP)
Download PDF: